“…Studies demonstrated elevated levels of cortisol in plasma, CSF, and 24-h urine samples, high CSF corticotrophin releasing hormone (CRH) levels, blunted responses to CRH administration, and non-suppression of cortisol secretion on the dexamethasone suppression test in MDD (Carroll et al, 1976, 1981; Jarrett et al, 1983; Nemeroff et al, 1984; Halbreich et al, 1985; Holsboer et al, 1985; Banki et al, 1987; Evans and Nemeroff, 1987; Rubin et al, 1987; Heim et al, 2001; Newport et al, 2003; Raison and Miller, 2003). HPA axis dysregulation was related to age (Nelson et al, 1984a,b; Bremmer et al, 2007), depression subtype (Brouwer et al, 2005), recurrence (Poor et al, 2004), and treatment response, albeit inconsistently (Nemeroff et al, 1991; De Bellis et al, 1993; Veith et al, 1993; McKay and Zakzanis, 2010). One potential confound was whether HPA axis dysregulation reflected clinical state or diagnostic trait.…”